FDA COMPLIANCE POLICY GUIDE Sec. 420.100 Adulteration of Drugs Under Section 501(b) and 501(c) of the Act. Direct Reference Seizure Authority for Adulterated Drugs Under Section 501(b) (CPG 7132a.03)
Title:
FDA COMPLIANCE POLICY GUIDE Sec. 420.100 Adulteration of Drugs Under Section 501(b) and 501(c) of the Act. Direct Reference Seizure Authority for Adulterated Drugs Under Section 501(b) (CPG 7132a.03)
Origin/Publisher:
Office of Regulatory Affairs, FDA
Document Type:
Compliance Policy Guide
Content:
Compliance Policy Guides explain the FDA policy on regulatory issues related to FDA laws and regulations. They also advise the field inspection staff about the FDA-standards to be applied when determining industry compliance.